ABX-MA1 - HY-P991609
Catalog #
HY-P991609
ABX-MA1 is a humanized IgG2 monoclonal antibody inhibitor targeting MCAM/MUC18. ABX-MA1 significantly decreases homotypic aggregation and heterotypic adhesion to HUVECs, and the formation of experimental lung metastasis. ABX-MA1 potently inhibits tumor growth, angiogenesis, and MMP-2 expression in A375SM/WM2664 xenograft mice model, promising for melanoma research[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-P991609/ABX-MA1-DataSheet-MedChemExpress.pdf |
|---|---|
| Quantity | Get quote |
| Shipping | Room temperature |
| Application | Cancer-Kinase/protease |
| CAS | 561063-60-3 |
| MWT | N/A |
| Clinical Information | No Development Reported |
| Target | MMP |
| Application: | Cancer-Kinase/protease |
|---|